Table A4.
Post-Treatment PET Evaluability Status of Patients Accrued to the Study
| Evaluability Status | No. of Patients | % |
|---|---|---|
| Total eligible patients | 234 | 100.0 |
| Inevaluable patients | 61 | 26.1 |
| Death | 26 | 11.1 |
| Medical comorbidity | 4 | 1.7 |
| Patient discontinued protocol treatment | 2 | 0.9 |
| Patient refused post-treatment scan | 9 | 3.8 |
| Patient explicitly withdraws from further study participation | 5 | 2.1 |
| Patient relocated 2.5 hours away from study center | 1 | 0.4 |
| Patient started nonprotocol therapy | 2 | 0.9 |
| Patient transferred to hospice | 1 | 0.4 |
| Post-treatment image not done on ACRIN-qualified scanner | 1 | 0.4 |
| Patient admitted to hospital; CT scan showed metastatic disease | 1 | 0.4 |
| Scheduling problem | 1 | 0.4 |
| SUVpeak not evaluable because of poor image quality | 2 | 0.9 |
| SUVpeak not evaluable because of patient having eaten | 1 | 0.4 |
| SUVpeak not provided by the institution for unknown reason. | 5 | 2.1 |
| Evaluable patients | 173 | 73.9 |
Abbreviations: ACRIN, American College of Radiology Imaging Network; CT, computed tomography; PET, positron emission tomography; SUVpeak, peak standardized uptake value.